Melanoma Stage Iiib clinical trials

Explore recruiting melanoma stage iiib clinical trials.

Recruiting melanoma stage iiib studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Melanoma Stage Iiib trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and Safety Study of Acasunlimab as Monotherapy and in Combination With Pembrolizumab in Subjects With Relapsed/Refractory, Unresectable Locally Advanced or Metastatic Cutaneous Melanoma That Progressed On or After Treatment With a Checkpoint Inhibitor

France, Spain, Netherlands, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Melanoma Stage Iiib trials by city

Melanoma Stage Iiib clinical trials

Recruiting melanoma stage iiib studies right now

The Multicentre Selective Lymphadenectomy Trial - 3

NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Also recruiting in Europe

Efficacy and Safety Study of Acasunlimab as Monotherapy and in Combination With Pembrolizumab in Subjects With Relapsed/Refractory, Unresectable Locally Advanced or Metastatic Cutaneous Melanoma That Progressed On or After Treatment With a Checkpoint Inhibitor

Melanoma Stage Iiib trials by city

Other conditions